TP53 and endometrial cancer: Cervical swab-based gDNA analysis can check for MMRd and p53 status, such that endometrial cancer patients can be categorised according to the ProMisE prior to undergoing hysterectomy, and therefore, has the potential to allow precision therapy for patients with endometrial cancer.